NC-PERCONA
27.3.2024 14:01:35 CET | Business Wire | Press release
Percona, a leader in enterprise-grade, open source database software, support, and services, has entered 2024 fresh off a year marked by sustained customer growth, multiple prestigious award wins, and innovative product enhancements. The company's impressive 2023 has further solidified its standing as a go-to provider of open source database solutions and support services.
Having predicted the database market to clear $100 billion in 2023, Gartner forecasts the market to grow at a compound annual growth rate (CAGR) of 16.8% through 2027 and reach $203.6 billion. This underscores sustained demand for sophisticated database management expertise to ensure optimal performance, security, and reliability. Uniquely qualified to address these needs, Percona has capitalized on the expanding opportunity, realizing a 19% increase in Annual Recurring Revenue (ARR).
Customer-Led Growth
Fueled by ongoing innovation and an unwavering commitment to customer success, Percona has continued to broaden its customer base — with both new customer acquisitions and expanded relationships with existing customers contributing to its fully organic growth.
One notable example, EveryMatrix, a prominent iGaming software provider, has benefited from Percona's managed services expertise, optimizing their database management for MySQL, MariaDB, and PostgreSQL. This collaboration has resulted in enhanced database performance, resilience, and security, empowering EveryMatrix to focus on innovation and customer satisfaction within the highly competitive online gaming industry.
Similarly, PagerDuty relies on Percona's support for MySQL, ensuring reliable and high-performance database instances critical to PagerDuty's operations. Percona's proactive assistance, including end-of-life support for MySQL 5.7 and migration planning, underscores its commitment to delivering exceptional support and expertise to its clientele.
2023 also saw some of the world’s most recognizable brands signing on with Percona or expanding the scope of their engagement. Percona began supporting companies such as Netflix and the United States Geological Survey. The company expanded its scope further by partnering with Merchant Warrior, Otto Office, and Kontron, among others.
Awards and Recognition
Percona’s track record as a leader in the open source database community yielded several prestigious awards and acknowledgments in 2023.
Most recently, the company secured the title of "Best DevOps for DataOps/Database Solution" at the Devops Dozen awards, illustrating its commitment to delivering cutting-edge solutions tailored to modern DevOps practices. Additionally, Percona's innovative products have been featured among the trend-setting products in data and information management for 2024 by DBTA (Database Trends and Applications), further validating its position as an industry trailblazer.
Moreover, Percona thought leaders like CEO Ann Schlemmer and Technology Evangelist Dave Stokes have garnered attention in publications such as Forbes, Computer Weekly, InfoWorld, The New Stack, The Register, and more. In these thought pieces Percona’s leaders have spearheaded discussions on data and open source, shaping the discourse around emerging trends and best practices.
Innovations and Enhancements
Percona continued to push the boundaries of database innovation with the recent Beta release of Percona Everest, an open source cloud-native database platform. Percona Everest is the first open source solution that combines multi-cloud and multi-database capabilities in one platform. With an intuitive user interface (UI) and command-line interface (CLI), Percona Everest offers advanced database provisioning and management features at no cost while providing control over infrastructure expenses, eliminating vendor lock-in.
Percona Everest allows users to enjoy flexible features such as provisioning, scalability, performance optimization, and high availability with full automation. By integrating with Kubernetes Operators, Percona Everest empowers users to run databases anywhere, liberating them from the constraints of public cloud platforms.
In addition to the Beta release of Percona Everest, Percona introduced numerous enhancements and updates to its product lineup over the course of 2023, including:
- A complete post-EOL support program for MySQL 5.7, which allows participating customers to continue to operate on a fully supported Percona Server for MySQL 5.7 until upgrading to later major versions becomes more convenient. Within this program, Percona continues to release the CVE-patched versions of MySQL 5.7 to participating customers.
- Percona Monitoring and Management (PMM) introduced MongoDB backup monitoring capabilities, which provide users with a streamlined backup and restore process and improved inventory management.
Primed for Growth
Looking ahead, Percona is poised for continued expansion. The company remains steadfast in its mission to make enterprise databases run better through a unique blend of expertise and open source software.
"As we reflect on our recent achievements and the strides we've made in 2023, it's clear that all the attributes customers value in a vendor – dedication to innovation, customer-centric solutions, and fostering meaningful relationships – are moving Percona in the right direction," said Ann Schlemmer, CEO of Percona. "We are proud of each milestone we’ve reached and the incredible team that has gotten us here, and we look forward to continuing our commitment to driving progress."
Percona will reaffirm its leadership within the open source database community by participating in key industry events throughout 2024, including KubeCon North America and Open Source Summit North America. At these events, and many others, Percona will continue to expand its impact on the open source database community.
Learn more about how databases perform better with Percona.
About Percona:
Percona is a world-class open source database software, support, and services company. The organization is dedicated to helping businesses ensure their databases — and the applications that depend on them — are secure, compliant, performant, and highly available.
Through a unique combination of database expertise and enterprise-grade open source software, Percona empowers organizations with the freedom to choose, the freedom to create, and the freedom to innovate with speed as they grow. For more information, visit www.percona.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240327240035/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom